Sun Pharmaceutical Industries Credit Rating
Sun Pharmaceutical Industries Limited announced that CRISIL and ICRA reaffirmed its 'AAA' and 'A1+' ratings. CRISIL placed the long-term rating on 'Watch with Developing Implications' following Sun Pharma's agreement to acquire Organon & Co.